Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

54.00

+0.50 (0.93%)

as of Jun 5, 2026, 8:00:00 pm Market Open.

1635 watching

Investor Insights

Jun 6, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) is viewed positively by many experts, who highlight its strong performance in Asia and robust wealth management services. The company is seen as a good long-term investment, particularly due to its attractive dividend yield and relatively low price-to-earnings ratio compared to banks. However, there are concerns regarding short-term earnings fluctuations, particularly in alternative portfolio results and U.S. operations. Market analysts suggest that while the stock has had a good run, cautious investors should watch for strategic entry points, as some believe it may be susceptible to macroeconomic challenges. Overall, the sentiment is that MFC is a solid income stock with potential for growth as it continues to navigate its complex business landscape.

Consensus

Hold

Valuation

Fair Value

Similar

GWO

BUY

Have put together 3 quarters in a row where they have started to turn around. Finally getting their act together. Great international growth. Well-positioned domestically in North America. Have controlled the market leverage much better.

DON'T BUY

Yield isn't too bad but there is still a bit of a cloud over it. Last quarterly results were excellent and they are working their way out of their problems. Certain amount of market exposure to some of their products. He would prefer Sun Life (SLF-T) or Great West (GWO-T).

DON'T BUY

Now is not the entry point. This is not where an investor should be. It is a value trap. There are a lot of issues that have to be worked out

BUY

Just reported great earnings, quite a bit better than the consensus was looking for. Well-positioned in Canada, US and Asia. Once they get beyond the current market conditions, you'll see the growth of the business lead to much higher multiples. Good value.

DON'T BUY

Good numbers in Q2, which they badly needed. Normally they do a readjustment to their actuarial assumptions in Q3 and that could be a one-time charge that will be material for them. He would watch for what that is before he would be comfortable with this as a long-term hold.

COMMENT

Had better than expected earnings but everyone is focused on interest rates and how they are hedged on them. Lower interest rates are bad for their earnings going forward. The underlying business is doing very well. At some point, interest rates will go up and this company will recover.

SELL

Held this for a long time but finally sold it recently. Equity risks are now being covered because they are now putting on more hedging. The big drop in bond yields has hurt insurance companies. Dynamics are poor.

BUY

Good time to load up. Sales are tremendous. Exposure to Asia is a good thing. Problem is the investment portfolio and sins of the past. Will be one of the better performing financial stocks in Canada. Non-bank financials are the place to be.

HOLD

It looks like the stock will come back into the $10 range. Last year the company said they needed 2 things for their business plan. They needed both the stock market and interest rates to go up.

PAST TOP PICK

(A Top Pick Aug 19/10. Up 15.38%.) Chart shows a low in 09 and another one in 2010 but the second one was a higher low. Has been dropping in 2011 because of QE2, which has put pressure on interest rates. Keep an eye on the US 10 year and watch for the yield to get back up through 3%, 3.5% and so on. Still a Hold.

COMMENT

This is a good entry point for someone with a 2-year outlook. Has a lot of sensitivity to the marketplace and interest rates. New management has worked to hedge this more. Doesn't expect they will have a very good quarter and continued market volatility will impact the earnings.

DON'T BUY

Not a fan. Doesn't like the US operations, which hurt them very badly in the last downturn. There huge acquisition of John Hancock hasn't really worked out that well. Still likes their Far East prospects and their Canadian operations.

WATCH

Was probably the most leveraged company to the stock and bond market coming of 2008. Have done an incredibly good job of de-leveraging in the last two years. Sees some decent upside potential. He has a $19 target, but is a little nervous on this given where interest rates and where the stock market has gone. $19 would be 18-24 months. Next quarter could be a little dicey for them.

BUY

Playing a dangerous game if it is just for the next quarter or two. Tremendous franchise. De-risked balance sheet dramatically. It is one of his largest holdings in that sector.

BUY

Doesn’t expect a dividend increase any time soon. Struggling through their problems with their GIC portfolios that are levered to equity markets and interest rates. Believes interest rates are going up, which is good for lifecos and over time he thinks equity markets will rise.

Showing 1,276 to 1,290 of 2,279 entries

Most Recent Experts

Jim Cramer - Mad Money

CNBC

Brian Madden

First Avenue Investment Counsel

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Darren Sissons

Campbell Lee & Ross

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)